Molecular detection and prognostic value of epithelial markers mRNA expression in peripheral blood of advanced non-small cell lung cancer patients

Cancer Biomarkers

Volumn 14, Issue 4, 2014, Pages 215-223

  Arrieta, Oscar ^a   Pineda, Benjamín ^b   Muñiz Hernández, Saé ^a   Flores, Diana ^a   Ordóñez, Graciela ^b   Borbolla Escoboza, Jose R ^c   Orta, David ^a  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

carcinoembryonic antigen; circulating tumor cells; Cytokeratins; lung cancer; prognosis

Indexed keywords

CARBOPLATIN; CARCINOEMBRYONIC ANTIGEN; CISPLATIN; CYTOKERATIN 18; CYTOKERATIN 19; MESSENGER RNA; PACLITAXEL; TUMOR MARKER;

A549 CELL LINE; ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSIS; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; GENETICS; LUNG TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; TREATMENT OUTCOME; TUMOR EMBOLISM; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; RNA, MESSENGER; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84908175902     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-140394     Document Type: Article

References (38)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, D. Forman, Global cancer statistics. CA Cancer J Clin 61 (2011), 69-90.
2. A.E. Ring, L. Zabaglo, M.G. Ormerod, Detection of circulating epithelial cells in the blood of patients with breast cancer: Comparison of three techniques, Br J Cancer 92 (2005), 906-12.
3. C.Y. Lu, Y.H. Uen, H.L. Tsai, S.C. Chuang, M.F. Hou, D.C. Wu, S.H. Juo, S.R. Lin, J.Y. Wang, Molecular detection of persistent postoperative circulating tumour cells in stages II and III colon cancer patients via multiple blood sampling: Prognostic significance of detection for early relapse, Br J Cancer 104 (2011), 1178-84.
4. E. Carrillo, J. Prados, C. Melguizo, J.A. Marchal, C. Vélez, S. Serrano, H. Boulaiz, J.A. Mérida, A. Aránega, Reverse transcriptase-polymerase chain reaction detection of circulating tumor cells in patients with melanoma: correlation with clinical stage, tumor thickness and histological type, Pathol Int 52 (2002), 294-9.
5. E. Saloustros, M. Perraki, S. Apostolaki, G. Kallergi, A. Xyrafas, K. Kalbakis, S. Agelaki, A. Kalykaki, V. Georgoulias, D. Mavroudis, Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse, Breast Cancer Res 13 (2011), R60.
6. E. Seregni, P. Foa, A. Bogni, C. Botti, I. Cataldo, M. Sala, M. Mezzetti, M. Gasparini, L. Santambrogio, D. Legnani, E. Bombardieri, Evaluation of the soluble fragments of cytokeratin 19 (CK19) in non-small cell lung cancer (NSCLC), Oncol Rep 3 (1996), 95-101.
7. E.A. Eisenhauer, P. Therasse, J. Bogaerts, L.H. Schwartz, D. Sargent, R. Ford, J. Dancey, S. Arbuck, S. Gwyther, M. Mooney, L. Rubinstein, L. Shankar, L. Dodd, R. Kaplan, D. Lacombe, J. Verweij, New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1), Eur J Cancer 45 (2009), 228-47.
8. E.A. Punnoose, S. Atwal, W. Liu, R. Raja, B.M. Fine, B.G. Hughes, R.J. Hicks, G.M. Hampton, L.C. Amler, A. Pirzkall, M.R. Lackner, Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib, Clin Cancer Res 18 (2012), 2391-401.
9. F. Kijima, S. Natsugoe, S. Takao, K. Aridome, M. Baba, M. Yoshifumi, Y. Eizuru, T. Aikou, Detection and clinical significance of lymph node micrometastasis determined by reverse transcription-polymerase chain reaction in patients with esophageal carcinoma, Oncology 58 (2000), 38-44.
10. G. Palmieri, P.A. Ascierto, F. Perrone, S.M. Satriano, A. Ottaiano, A. Daponte, M. Napolitano, C. Caracò, N. Mozzillo, M.T. Melucci, A. Cossu, F. Tanda, C. Gallo, R.A. Satriano, G. Castello, Prognostic value of circulating melanoma cells detecte d by reverse transcriptase-polymerase chain reaction, J Clin Oncol 21 (2003), 767-73.
11. G.D. Young, T.S Winokur, R.J. Cerfolio, B.A. Van Tine, L.T. Chow, V. Okoh, R.I. Jr Garver RI , Differential expression and biodistribution of cytokeratin 18 and desmoplakins in nonsmall cell lung carcinoma subtypes, Lung Cancer 36 (2002), 133-41.
12. H.Y. Wang, J.M. Sun, H.F. Lu, D.R. Shi, Z.L. Ou, Y.L. Ren, S.Q. Fu, Micrometastases detected by cytokeratin 19 expression in sentinel lymph nodes of patients with early-stage cervical cancer, Int J Gynecol Cancer 16 (2006), 643-8.
13. J. Maeda, M. Inoue, M. Okumura, M. Ohta, M. Minami, H . Shiono, Y. Shintani, H. Matsuda, N. Matsuura, Detection of occult tumor cells in lymph nodes from non-small cell lung cancer patients using reverse transcription-polymerase chain reaction for carcinoembryonic antigen mRNA with the evaluation of its sensitivity, Lung Cancer 52 (2006), 235-40.
14. J. Yamashita, A. Matsuo, Y. Kurusu, T. Saishoji, N. Hayashi, M. Ogawa, Preoperative evidence of circulating tumor cells by means of reverse transcriptase-polymerase chain reaction for carcinoembryonic antigen messenger RNA is an independent predictor of survival in non-small cell lung cancer: a prospective study, J Thorac Cardiovasc Surg 124 (2002), 299-305.
15. K. Peck, Y.P. Sher, J.Y. Shih, S.R. Roffler, C.W. Wu, P.C. Yang, Detection and quantitation of circulating cancer cells in the peripheral blood of lung cancer patients, Cancer Res 58 (1998), 2761-5.
16. L. Liu, G.Q. Liao, P. He, H. Zhu, P.H. Liu, Y.M. Qu, X.M. Song, Q.W. Xu, Q. Gao, Y. Zhang, W.F. Chen, Y.H. Yin, Detection of circulating cancer cells in lung cancer patients with a panel of marker genes, Biochem Biophys Res Commun 372 (2008), 756-60.
17. L.A. Devriese, A.J. Bosma, M.M van de Heuvel, W. Heemsbergen, E.E. Voest, J.H. Schellens, Circulating tumor cell detection in advanced non-small cell lung cancer patients by multi-marker QPCR analysis, Lung Cancer 75 (2012), 242-7.
18. M. Daskalakis, D. Mavroudis, E. Sanidas, S. Apostolaki, I. Askoxylakis, E. de Bree, V. Georgoulias, J. Melissas, Assessment of the effect of surgery on the kinetics of circulating tumour cells in patients with operable breast cancer based on cytokeratin-19 mRNA detection, Eur J Surg Oncol 37 (2011), 404-10.
19. M. Gerhard, H. Juhl, H. Kalthoff, H.W. Schreiber, C. Wagener, M. Neumaier, Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction, J Clin Oncol 12 (1994), 725-9.
20. M. Wendel, L. Bazhenova, R. Boshuizen, A. Kolatkar, M. Honnatti, E.H. Cho, D. Marrinucci, A. Sandhu, A. Perricone, P. Thistlethwaite, K. Bethel, J. Nieva, Mv. Heuvel, P. Kuhn, Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology, Phys Biol 9 (2012), 016005.
21. M.G. Krebs, R. Sloane, L. Priest, L. Lancashire, J.M. Hou, A. Greystoke, T.H. Ward, R. Ferraldeschi, A. Hughes, G. Clack, M. Ranson, C. Dive, F.H. Blackhall, Evaluation and prognostic significance of circulating tumor cells in patients with nonsmall- cell lung cancer, J Clin Oncol 29 (2011), 1556-63.
22. N. Xenidis, M. Ignatiadis, S. Apostolaki, M. Perraki, K. Kalbakis, S. Agelaki, E.N. Stathopoulos, G. Chlouverakis, E. Lianidou, S. Kakolyris, V. Georgoulias, D. Mavroudis, Cytokeratin-19 mRNA-Positive Circulating Tumor Cells After Adjuvant Chemotherapy in Patients With Early Breast Cancer, J Clin Oncol 27 (2009), 2177-84.
23. N.M. Brown, T.T. Stenzel, P.N. Friedman, Evaluation of expression based markers for the detection of breast cancer cells, Breast Cancer Res Treat 97 (2006), 41-47.
24. O. Arrieta, D. Saavedra-Perez, R. Kuri, A. Aviles-Salas, L. Martinez, D. Mendoza-Posada, P. Castillo, A. Astorga, E. Guzman, J. De la Garza, Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: A prospective analysis, BMC Cancer 9 (2009), 119.
25. O. Arrieta, E. Guzman de Alba, L.F. Alba-Lopez, A. Acosta- Espinoza, National consensus of diagnosis and treatment of non-small cell lung cancer. Rev Invest Clin 65 (2013), 5-84.
26. P. Huang, J. Wang, Y. Guo, W. Xie, Molecular detection of disseminated tumor cells in the peripheral blood in patients with gastrointestinal cancer, J Cancer Res Clin Oncol 129 (2003), 192-8.
27. P.J. Bostick, S. Chatterjee, D.D. Chi, K.T. Huynh, A.E. Giuliano, R. Cote, D.S. Hoon, Limitations of specific reversetranscriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients, J Clin Oncol 16 (1998), 2632-40.
28. R. Boshuizen, P. Kuhn, M. van den Heuvel, Circulating tumor cells in non-small cell lung carcinoma, J Thorac Dis 4 (2012), 456-8.
29. R. Cutait, V.A. Alves, L.C. Lopes, D.E. Cutait, J.L. Borges, J. Singer, J.H. da Silva, F.S. Goffi, Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins, Dis Colon Rectum 34 (1991), 917-20.
30. R. Hampton, M. Walker, J. Marshall, H. Juhl, Differential expression of carcinoembryonic antigen (CEA) splice variants in whole blood of colon cancer patients and healthy volunteers: implication for the detection of circulating colon cancer cells, Oncogene 21 (2002), 7817-23.
31. R. Moll, M. Divo, L. Langbein, The human keratins: Biology and pathology, Histochem Cell Biol 129 (2008), 705-33.
32. R. Siegel, E. Ward, O. Brawley, A. Jemal, Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths, CA Cancer J Clin 61 (2011), 212-36.
33. R.A. Ghossein and S. Bhattacharya, Molecular detection and characterisation of circulating tumour cells and micrometastases in solid tumours, Eur J Cancer 36 (2000), 1681-94.
34. R.J. Cote, E.J. Beattie, B. Chaiwun, S.R. Shi, J. Harvey, S.C. Chen, A.E. Sherrod, S. Groshen, C.R Taylor, Detection of occult bone marrow micrometastases in patients with operable lung carcinoma, Ann Surg 222 (1995), 415-23; discussion 423-5.
35. T.F. Chen, G.L. Jiang, X.L. Fu, L.J. Wang, H. Qian, K.L. Wu, S. Zhao, CK19 mRNA expression measured by reversetranscription polymerase chain reaction (RT-PCR) in the peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation: An independent prognostic factor, Lung Cancer 56 (2007), 105-14.
36. V. Hirsh, L. Paz-Ares, M. Boyer, R. Rosell, G. Middleton, W.E. Eberhardt, A. Szczesna, P. Reiterer, M. Saleh, O. Arrieta, E. Bajetta, R.T. Webb, J. Raats, R.J. Benner, C. Fowst, S.J. Meech, D. Readett, J.H. Schiller, Randomized phase III trial of paclitaxel/carboplatin with or without PF-3512676 (Tolllike receptor 9 agonist) as first-line treatment for advanced non-small-cell lung cancer. J Clin Oncol 29 (2011), 2667-74.
37. Y. Kurusu, J. Yamashita, M. Ogawa, Detection of circulating tumor cells by reverse transcriptase-polymerase chain reaction in patients with resectable non-small-cell lung cancer Surgery 126 (1999), 820-6.
38. Y.P. Sher, J.Y. Shih, P.C. Yang, S.R. Roffler, Y.W. Chu, C.W. Wu, C.L. Yu, K. Peck, Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes, Clin Cancer Res 11 (2005), 173-9.